A Study in Chinese Patients With Acquired Blepharoptosis

NCT06683651 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Blepharoptosis

Interventions

DRUG: STN1013800 ophthalmic solution
DRUG: STN1013800 ophthalmic solution Liquid Base, without STN1013800

Sponsor

Santen Pharmaceutical Co., Ltd.